Physician profile
Cassandra Lyons
NPI 1972167237
$3,040.11
in general payments reported to CMS, 2019-2025
7 companies · $1,747 in 2025
The $1,747 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.74 · 2023: $854 · 2024: $364 · 2025: $1,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813 · Travel and Lodging: $1,002 · Grant: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.21 |
| Travel and Lodging | $1,001.60 |
| Grant | $150.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,454.65 | 2023-2025 | Titan |
| Boston Scientific Corporation | $980.49 | 2023-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, General - Therapies |
| Medtronic, INC. | $208.86 | 2022-2023 | Interstim |
| Endo USA, INC. | $125.37 | 2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $107.86 | 2025 | Keytruda |
| Antares Pharma, INC. | $100.00 | 2022-2023 | Xyosted, Tlando |
| Astrazeneca Pharmaceuticals LP | $62.88 | 2023 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.